192 related articles for article (PubMed ID: 34793863)
1. Antioxidant interventions in autism spectrum disorders: A meta-analysis.
Liu Y; Yang Z; Du Y; Shi S; Cheng Y
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 113():110476. PubMed ID: 34793863
[TBL] [Abstract][Full Text] [Related]
2. A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder.
Wink LK; Adams R; Wang Z; Klaunig JE; Plawecki MH; Posey DJ; McDougle CJ; Erickson CA
Mol Autism; 2016; 7():26. PubMed ID: 27103982
[TBL] [Abstract][Full Text] [Related]
3. Dietary Interventions for Autism Spectrum Disorder: A Meta-analysis.
Fraguas D; Díaz-Caneja CM; Pina-Camacho L; Moreno C; Durán-Cutilla M; Ayora M; González-Vioque E; de Matteis M; Hendren RL; Arango C; Parellada M
Pediatrics; 2019 Nov; 144(5):. PubMed ID: 31586029
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness and adverse effects of D-cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder.
Aye SZ; Ni H; Sein HH; Mon ST; Zheng Q; Wong YKY
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013457. PubMed ID: 33583058
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of
Lee TM; Lee KM; Lee CY; Lee HC; Tam KW; Loh EW
Aust N Z J Psychiatry; 2021 Feb; 55(2):196-206. PubMed ID: 32900213
[TBL] [Abstract][Full Text] [Related]
6. Effect of probiotics on children with autism spectrum disorders: a meta-analysis.
Zeng P; Zhang CZ; Fan ZX; Yang CJ; Cai WY; Huang YF; Xiang ZJ; Wu JY; Zhang J; Yang J
Ital J Pediatr; 2024 Jun; 50(1):120. PubMed ID: 38902804
[TBL] [Abstract][Full Text] [Related]
7. Possible effects of N-acetylcysteine in autism spectrum disorders: major clinical aspects, eating behaviors, and sleeping habits.
Nalbant K; Erden S
Turk J Pediatr; 2023; 65(5):832-844. PubMed ID: 37853974
[TBL] [Abstract][Full Text] [Related]
8. Randomized, Placebo-Controlled Trial of Methyl B12 for Children with Autism.
Hendren RL; James SJ; Widjaja F; Lawton B; Rosenblatt A; Bent S
J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):774-783. PubMed ID: 26889605
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled clinical trial.
Momtazmanesh S; Amirimoghaddam-Yazdi Z; Moghaddam HS; Mohammadi MR; Akhondzadeh S
Psychiatry Clin Neurosci; 2020 Jul; 74(7):398-405. PubMed ID: 32347624
[TBL] [Abstract][Full Text] [Related]
10. Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis.
Siafis S; Çıray O; Schneider-Thoma J; Bighelli I; Krause M; Rodolico A; Ceraso A; Deste G; Huhn M; Fraguas D; Mavridis D; Charman T; Murphy DG; Parellada M; Arango C; Leucht S
Mol Autism; 2020 Aug; 11(1):66. PubMed ID: 32847616
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological and non-pharmacological interventions for irritability in autism spectrum disorder: a systematic review and meta-analysis with the GRADE assessment.
Choi H; Kim JH; Yang HS; Kim JY; Cortese S; Smith L; Koyanagi A; Dragioti E; Radua J; Fusar-Poli P; Shin JI; Cheon KA; Solmi M
Mol Autism; 2024 Jan; 15(1):7. PubMed ID: 38263251
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.
Hardan AY; Fung LK; Libove RA; Obukhanych TV; Nair S; Herzenberg LA; Frazier TW; Tirouvanziam R
Biol Psychiatry; 2012 Jun; 71(11):956-61. PubMed ID: 22342106
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial.
Hendouei F; Sanjari Moghaddam H; Mohammadi MR; Taslimi N; Rezaei F; Akhondzadeh S
J Clin Pharm Ther; 2020 Apr; 45(2):324-334. PubMed ID: 31714621
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder.
Zimmerman AW; Singh K; Connors SL; Liu H; Panjwani AA; Lee LC; Diggins E; Foley A; Melnyk S; Singh IN; James SJ; Frye RE; Fahey JW
Mol Autism; 2021 May; 12(1):38. PubMed ID: 34034808
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of vitamin D supplementation in children with autism spectrum disorder.
Saad K; Abdel-Rahman AA; Elserogy YM; Al-Atram AA; El-Houfey AA; Othman HA; Bjørklund G; Jia F; Urbina MA; Abo-Elela MGM; Ahmad FA; Abd El-Baseer KA; Ahmed AE; Abdel-Salam AM
J Child Psychol Psychiatry; 2018 Jan; 59(1):20-29. PubMed ID: 27868194
[TBL] [Abstract][Full Text] [Related]
16. The effect of nutritional interventions reducing oxidative stress on behavioural and gastrointestinal problems in autism spectrum disorder.
Colak H; Sariyer ET; Nogay NH
Int J Dev Neurosci; 2023 Apr; 83(2):135-164. PubMed ID: 36843243
[TBL] [Abstract][Full Text] [Related]
17. Systematic review and guide to management of core and psychiatric symptoms in youth with autism.
Ameis SH; Kassee C; Corbett-Dick P; Cole L; Dadhwal S; Lai MC; Veenstra-VanderWeele J; Correll CU
Acta Psychiatr Scand; 2018 Nov; 138(5):379-400. PubMed ID: 29904907
[TBL] [Abstract][Full Text] [Related]
18. Oxytocin treatment for core symptoms in children with autism spectrum disorder: a systematic review and meta-analysis.
Hu L; Du X; Jiang Z; Song C; Liu D
Eur J Clin Pharmacol; 2023 Oct; 79(10):1357-1363. PubMed ID: 37540265
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled Trials.
Arteaga-Henríquez G; Gisbert L; Ramos-Quiroga JA
CNS Drugs; 2023 Mar; 37(3):215-229. PubMed ID: 36913130
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic Replacement Therapy for Maladaptive Behaviors in Preschool Children With Autism Spectrum Disorder.
Pearson DA; Hendren RL; Heil MF; McIntyre WR; Raines SR
JAMA Netw Open; 2023 Nov; 6(11):e2344136. PubMed ID: 38032645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
